CH640530A5 - Process for preparing mefloquine - Google Patents

Process for preparing mefloquine Download PDF

Info

Publication number
CH640530A5
CH640530A5 CH169578A CH169578A CH640530A5 CH 640530 A5 CH640530 A5 CH 640530A5 CH 169578 A CH169578 A CH 169578A CH 169578 A CH169578 A CH 169578A CH 640530 A5 CH640530 A5 CH 640530A5
Authority
CH
Switzerland
Prior art keywords
trifluoromethyl
bis
quinoline
methanol
erythro
Prior art date
Application number
CH169578A
Other languages
German (de)
English (en)
Inventor
Guenter Grethe
Toomas Mitt
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CH640530A5 publication Critical patent/CH640530A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
CH169578A 1977-02-17 1978-02-16 Process for preparing mefloquine CH640530A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76981677A 1977-02-17 1977-02-17

Publications (1)

Publication Number Publication Date
CH640530A5 true CH640530A5 (en) 1984-01-13

Family

ID=25086585

Family Applications (2)

Application Number Title Priority Date Filing Date
CH169578A CH640530A5 (en) 1977-02-17 1978-02-16 Process for preparing mefloquine
CH301282A CH640531A5 (en) 1977-02-17 1982-05-14 Alpha-2-pyridyl-2,8-bis-(trifluoromethyl)-4-quinolinemethanol

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH301282A CH640531A5 (en) 1977-02-17 1982-05-14 Alpha-2-pyridyl-2,8-bis-(trifluoromethyl)-4-quinolinemethanol

Country Status (9)

Country Link
JP (1) JPS53103478A (nl)
AT (1) AT358044B (nl)
BE (1) BE864002A (nl)
CH (2) CH640530A5 (nl)
DE (1) DE2806909A1 (nl)
FR (1) FR2381044A1 (nl)
GB (1) GB1594282A (nl)
IT (1) IT1158450B (nl)
NL (1) NL7801787A (nl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2940443A1 (de) * 1979-10-05 1981-04-16 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von erythro-(alpha)-2-piperidyl-2,8-bis-(trifluormethyl)-4-chinolin-methanol
FR2485014A1 (fr) * 1980-06-20 1981-12-24 Pharmindustrie Nouveaux derives de (quinolyl-2, -3 ou -4)-1 (piperidyl ou pyrrolidinyl-2 ou -3)-2 ou -3 ethanone ou propanone, procedes pour leur preparation, et leur utilisation comme medicaments
US4507482A (en) * 1982-04-14 1985-03-26 Hoffmann-La Roche Inc. Purification of mefloquin hydrochloride
DK160499C (da) * 1982-09-10 1991-08-26 Hoffmann La Roche Fremgangsmaade til fremstilling af mefloquin og mellemprodukt til anvendelse herved
JPH0234129U (nl) * 1989-05-25 1990-03-05
HUT54363A (en) * 1989-07-25 1991-02-28 Alkaloida Vegyeszeti Gyar Process for producing pyridyl-methyl-quinolin derivatives
GB9819382D0 (en) * 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH590274A5 (nl) * 1970-03-16 1977-07-29 Hoffmann La Roche
CH605916A5 (nl) * 1973-12-07 1978-10-13 Hoffmann La Roche

Also Published As

Publication number Publication date
IT1158450B (it) 1987-02-18
BE864002A (fr) 1978-08-16
ATA113378A (de) 1980-01-15
IT7820331A0 (it) 1978-02-16
FR2381044A1 (fr) 1978-09-15
GB1594282A (en) 1981-07-30
JPS6257631B2 (nl) 1987-12-02
AT358044B (de) 1980-08-11
DE2806909A1 (de) 1978-08-24
NL7801787A (nl) 1978-08-21
CH640531A5 (en) 1984-01-13
DE2806909C2 (nl) 1988-04-07
JPS53103478A (en) 1978-09-08
FR2381044B1 (nl) 1983-06-10

Similar Documents

Publication Publication Date Title
DE2614406C2 (nl)
EP0496238A1 (de) Substituierte Benzoxazepine und Benzthiazepine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE2812578A1 (de) 1-aminoindane und verfahren zu ihrer herstellung
DE2741233A1 (de) Verfahren zur herstellung von methoxypsoralen
DE2806909C2 (nl)
DE69909848T2 (de) Verfahren zur herstellung substituierter allylamin derivative und deren salze
DD229126A5 (de) Verfahren zur herstellung von tetronsaeure
CH639639A5 (en) Alpha-fluoromethyl-alpha-amino-alkanoic acids and their esters
DE2514673C2 (de) Benzo[b]bicyclo[3.3.1]nona-3,6a(10a)diene, Verfahren zu ihrer Herstellung und diese enthaltende anorektische Mittel
DD219765A5 (de) Verfahren zur herstellung von substituierten hexahydropyrrolo (-1,2-a)-chinolin-, hexahydro-1h-pyrido (1,2-a)chinolin-, hexahydrobenzo(e)inden- und octahydrophenanthren-zns-mitteln
CH653996A5 (de) Tryptaminderivate und verfahren zu deren herstellung.
DE2833892C2 (de) 12H-Dibenzo[d,g][1,3,6]dioxazocinderivate, solche enthaltende Arzneimittel und Verfahren zur Herstellung derselben
CH619683A5 (nl)
DE3300522C2 (nl)
DE2845857A1 (de) Benzo eckige klammer auf d eckige klammer zu thiazolderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittelzubereitungen
DE68905361T2 (de) Trienische Derivate mit chromenischer Struktur, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
EP0019157A1 (de) 5,6-Dihydro-11-alkylen-morphantridin-6-one und Verfahren zu ihrer Herstellung
EP0180890B1 (de) Verfahren zur diastereoselektiven Reduktion von 3-Amino-1-benzoxepin-5(2H)-onen
DE2834312C2 (de) Verfahren zur Herstellung von 2[N-(2-Hydroxyäthyl)-N-niederalkylaminomethyl]-benzhydrolen
DE3403778A1 (de) Cyanomethyl-(2-cyano-ethyl)-(3-hydroxy-propyl)-amin seine verwendung zur herstellung von 1-(3-hydroxy-propyl)-1,4-diazepan und 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-diazepan
DE3906460C1 (nl)
DE2644789A1 (de) Alkylen-di-phenylalk(en)ylcarbonsaeuren und ihre herstellung und verwendung
CH621782A5 (nl)
EP0650966A1 (de) Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates
AT250338B (de) Verfahren zur Herstellung neuer, basischer Derivate von substituierten Benzofuran-2-carbonsäuren und deren Salzen

Legal Events

Date Code Title Description
PUE Assignment

Owner name: F. HOFFMANN-LA ROCHE AG

PL Patent ceased